Literature DB >> 7214793

Analgesic drugs in breast milk and plasma.

J W Findlay, R L DeAngelis, M F Kearney, R M Welch, J M Findlay.   

Abstract

The disposition of salicylic acid, phenacetin, caffeine, and codeine, and two metabolites, acetaminophen and morphine, was studied in breast milk and plasma of two lactating mothers after single oral doses of a compound analgesic. Salicylic acid penetrated poorly into milk, with peak levels of only 1.12 to 1.60 micrograms/ml, whereas peak plasma levels were 33 to 43.4 micrograms/ml. The drug was also eliminated more slowly from milk than plasma. In contrast, caffeine and phenacetin kinetics in breast milk and plasma were similar, but milk levels were somewhat lower than plasma levels in both subjects. Metabolically produced acetaminophen levels in both fluids were much higher than those of the parent drug, phenacetin, in one subject, but early plasma and milk phenacetin levels exceeded those of acetaminophen in the other subject, thereafter dropping sharply to assume the pattern of the first subject. Elimination of the metabolite, acetaminophen, from milk was slower than from plasma (subject 1, half-life (t1/2) of drug in milk, 4.7 hr; t1/2 in plasma, 2.9 hr). In both subjects codeine concentrations in milk were 1.5 to 2.4 times as high as in plasma at the same times after drug. Metabolically produced morphine levels in milk from both mothers were low but exceeded those in plasma after 1 hr. Calculations based on average milk concentrations over the 12 hr after drug in subject 1 revealed milk excretion of 0.7% or less of the ingested dose of each drug. Similar calculations based on predicted steady-state milk drug concentrations in subject 2 indicated maximum milk excretion of 2.7% of the dose. In each case caffeine was excreted in the milk in the greatest amount.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7214793     DOI: 10.1038/clpt.1981.87

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  19 in total

Review 1.  Analgesics and breast-feeding: safety considerations.

Authors:  O Spigset; S Hägg
Journal:  Paediatr Drugs       Date:  2000 May-Jun       Impact factor: 3.022

2.  Prediction of drug distribution into human milk from physicochemical characteristics.

Authors:  H C Atkinson; E J Begg
Journal:  Clin Pharmacokinet       Date:  1990-02       Impact factor: 6.447

3.  A cost-effectiveness analysis of maternal CYP2D6 genetic testing to guide treatment for postpartum pain and avert infant adverse events.

Authors:  M E Moretti; D F Lato; H Berger; G Koren; S Ito; W J Ungar
Journal:  Pharmacogenomics J       Date:  2017-07-11       Impact factor: 3.550

4.  Drugs taken by mothers in the puerperium: inpatient survey in Northern Ireland.

Authors:  C M Passmore; J C McElnay; P F D'Arcy
Journal:  Br Med J (Clin Res Ed)       Date:  1984-12-08

Review 5.  Clinically relevant genetic variations in drug metabolizing enzymes.

Authors:  Navin Pinto; M Eileen Dolan
Journal:  Curr Drug Metab       Date:  2011-06       Impact factor: 3.731

6.  Passage of paracetamol into breast milk and its subsequent metabolism by the neonate.

Authors:  L J Notarianni; H G Oldham; P N Bennett
Journal:  Br J Clin Pharmacol       Date:  1987-07       Impact factor: 4.335

7.  Establishing causality of CNS depression in breastfed infants following maternal codeine use.

Authors:  Parvaz Madadi; Farshad Shirazi; Frank G Walter; Gideon Koren
Journal:  Paediatr Drugs       Date:  2008       Impact factor: 3.022

Review 8.  Non-narcotic analgesics. Use in pregnancy and fetal and perinatal effects.

Authors:  M A Heymann
Journal:  Drugs       Date:  1986       Impact factor: 9.546

9.  Excretion of dipyrone metabolites in human breast milk.

Authors:  E Zylber-Katz; N Linder; L Granit; M Levy
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

10.  Age-related difference in susceptibility of Apc(Min/+) mice towards the chemopreventive efficacy of dietary aspirin and curcumin.

Authors:  S Perkins; A R Clarke; W Steward; A Gescher
Journal:  Br J Cancer       Date:  2003-05-06       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.